普健生物(武汉)科技有限公司

首页 产品目录 产品目录(简版) 公司动态 企业认证 企业体检 公司相册 联系我们

武汉艾必赛生物有限公司推荐Anti-Human CD331/FGFR1 Antibody (A08),精品抗体

发布人:普健生物(武汉)科技有限公司

发布日期:2026/4/9 17:13:51

链接:https://www.abinscience.cn/product/40/3812.html

名称:Anti-Human CD331/FGFR1 Antibody (A08) 

Accession号:P11362

货号:HY105107

种属反应性:Human

宿主:Mouse

形式:Liquid

纯度:>95% as determined by SDS-PAGE.

克隆性:Monoclonal

同种型:IgG2a, kappa

应用:FCM

靶点:FLT2,  HBGFR, BFGFR, FGFR-1, CEK, Fibroblast growth factor receptor 1, FGFR1,  bFGF-R-1, Fms-like tyrosine kinase 2, FGFBR, FLT-2, CD331, Basic  fibroblast growth factor receptor 1, FLG, Proto-oncogene c-Fgr, N-sam

用途范围:仅用于科研

储存:Use  a manual defrost freezer and avoid repeated freeze-thaw cycles. Store  at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C  long term.

 

产品介绍:Anti-Human  CD331/FGFR1 Antibody (A08) 是艾必赛 (abinScience)  推出的一款高性能小鼠源单克隆抗体。该抗体特异性靶向人成纤维细胞生长因子受体1 (Fibroblast Growth Factor  Receptor 1),也称为 CD331 或 FGFR1。FGFR1  是一种关键的酪氨酸激酶受体,在调控胚胎发育、细胞增殖、分化与迁移等基本生物学过程中扮演着核心角色,是研究骨骼发育、肿瘤发生及代谢性疾病的重要靶点。本品克隆号为  A08,同种型为 IgG1, kappa,通过 Protein A/G 方法从细胞培养上清中纯化,经SDS-PAGE检测纯度高于  95%,确保了产品的高纯度与批间一致性。该抗体已通过流式细胞术 (FCM) 严格验证。实验数据显示,在 MCF7  细胞中,本品能产生强烈的特异性荧光信号,与同型对照相比区分显著,适用于对人源细胞或组织样本中 CD331/FGFR1  蛋白的表达进行精准检测与分析。


图片.png

 

产品购买联系方式:027-87433958/17302791434

邮箱:info@abinscience.com

 

参考文献:

1. FGFR1-related congenital hypogonadotropic hypogonadism: a case report and literature review. PMID: 41108094


2. FGFR1 mutations in Kallmann syndrome. PMID: 20389085


3. A FGFR1 inhibitor patent review: progress since 2010. PMID: 27976968


4. FGFR1 wild-type rosette-forming glioneuronal tumours. PMID: 39167187


5. FGFR1 variants contributed to families with tooth agenesis. PMID: 37833774


6. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma. PMID: 38607246


7. Novel FGFR1 Variants Are Associated with Congenital Scoliosis. PMID: 34440300


8.  [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked  to rearrangements within the chromosomal region 8p11-12]. PMID: 11174118


9. The D647N mutation of FGFR1 induces ligand-independent receptor activation. PMID: 37778450


10.  The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription  Factor FOXQ1 to Promote Breast Cancer Cell Growth. PMID: 36778115


11. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors. PMID: 35018490


12.  FGFR1 governs iron homeostasis via regulating intracellular protein  degradation pathways of IRP2 in prostate cancer cells. PMID: 39154074


13. New Phenotypic Features in FGFR1-Related Osteoglophonic Dysplasia. PMID: 40260920


14. Uterine Sarcoma With FGFR1-TACC1 Gene Fusion: A Case Report and Review of the Literature. PMID: 36302190


15. Deficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS. PMID: 36969192


16.  Prognostic value of FGFR1 expression and amplification in patients with  HNSCC: A systematic review and meta-analysis. PMID: 33989301


17. The sum is greater than the FGFR1 partner. PMID: 15050910


18. Dysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder. PMID: 40813470


19.  FGFR1 copy number in breast cancer: associations with proliferation,  histopathological grade and molecular subtypes. PMID: 33753561


20.
Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer. PMID: 37909331


21.  FGFR1 promotes tumor immune evasion via YAP-mediated PD-L1 expression  upregulation in lung squamous cell carcinoma. PMID: 35870429


详情请咨询 abinScience 亚洲区官方子公司 —— 武汉艾必赛生物技术有限公司

官方网址:【中文】
https://www.abinscience.cn

【英文】https://www.abinscience.com



武汉艾必赛生物技术有限公司成立于 2023 年,是 abinScience 在亚洲地区设立的官方全资子公司,全面负责 abinScience 品牌在亚太市场的科研试剂推广、销售及技术支持工作。

依托严格的产品研发体系和国际化的质量管理标准,武汉艾必赛与 AtaGenix、ProteoGenix 等知名品牌保持长期战略合作,现已构建起涵盖抗体、重组蛋白、工具酶、试剂盒、实验耗材在内的多品类供应体系,面向区域内科研机构、高校实验室与生物医药企业,提供稳定、高效、可信赖的产品与服务。

核心业务覆盖:
✅ 抗体产品(单抗、多抗、重组抗体等)
✅ 蛋白与多肽试剂(标签蛋白、功能蛋白等)
✅ 分子与细胞实验相关耗材
✅ 定制化研发服务(蛋白表达、抗体定制、亲和力成熟等)
✅ 科研供应链整合与项目配套支持

武汉艾必赛始终秉持“Empowering Bioscience Discovery”的理念,为亚太地区的生命科学研究持续注入高质量动能。


图片.png



相关新闻资讯

武汉艾必赛生物有限公司推荐Research Grade Retatrutide ,精品抗体

2026/06/26

链接:https://www.abinscience.cn/product/71/27542.html名称:Research Grade Retatrutide货号:SW328046种属反应性:Human应用:ELISA, Functional assay, Research in vivo同种型:Biosynthetic peptide.种属:Human克隆类型:Monoclonal靶标:GLP

武汉艾必赛生物有限公司推荐InVivoMAb Anti-SEBOV/ZEBOV GP/Envelope glycoprotein Antibody (Iv0198) ,精品抗体

2026/06/24

链接:https://www.abinscience.cn/product/68/16504.html名称:InVivoMAb Anti-SEBOV/ZEBOV GP/Envelope glycoprotein Antibody (Iv0198)货号:VK623050种属反应性:Ebola virus, Zaire ebolavirus, Zaire ebolavirus (strain Mayi

abinScience助力华中科技大学揭示磷脂酰丝氨酸外翻红细胞膜囊泡增强人工血管胞葬与重构机制

2026/06/23

小口径血管移植物(内径<6 mm)的临床缺口是心血管外科领域长期未解决的难题。自体血管取材有限、供区损伤风险高,而现有合成材料(如ePTFE)面临持续炎症、钙化和内膜增生等问题,至今仍无理想的小口径人工血管产品进入临床。红细胞膜囊泡(EMVs)因其良好的生物相容性和免疫逃逸特性,已被广泛用于纳米药物递送。然而,这一"don't eat me"策略仅利用了红细胞膜的被动免疫属性,其主动免疫调控潜力尚